Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IMW 2019 | Is ASCT the right answer for all transplant eligible MM patients?

Francesca Gay • 15 Sep 2019
IMW 2019
Multiple Myeloma

Francesca Gay, MD, of University of Turin, Turin, Italy, debates whether ASCT is the right answer for all transplant eligible myeloma patients. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Francesca Gay

An insight into designing randomized studies in high-risk myeloma
Binod Dhakal et al. • 4 Nov 2024
FORTE: MRD by MFC or NGS in myeloma 1:46
FORTE: MRD by MFC or NGS in myeloma
Francesca Gay • 14 Dec 2020
MRD: Paving the way for future clinical trials in myeloma 1:30
MRD: Paving the way for future clinical trials in myeloma
Francesca Gay • 14 Dec 2020
FORTE: KRd versus KCd treatment for myeloma 0:45
FORTE: KRd versus KCd treatment for myeloma
Francesca Gay • 14 Dec 2020

Related Videos

Initial results from MajesTEC-3: Tec-Dara versus DPd/DVd in patients with R/R multiple myeloma 3:53
Initial results from MajesTEC-3: Tec-Dara versus DPd/DVd in patients with R/R multiple myeloma
Luciano Costa • 16 Dec 2025
Belantamab mafodotin in functional high-risk RRMM: subgroup analysis of DREAMM-7 and DREAMM-8 4:02
Belantamab mafodotin in functional high-risk RRMM: subgroup analysis of DREAMM-7 and DREAMM-8
Meral Beksac • 10 Dec 2025
Incidence and risk factors for infections in NDMM treated with modern induction regimens 1:54
Incidence and risk factors for infections in NDMM treated with modern induction regimens
Efstathios Kastritis • 7 Dec 2025
A real-world analysis of infections in patients with RRMM receiving ide-cel 3:59
A real-world analysis of infections in patients with RRMM receiving ide-cel
Muhammad Bilal Abid • 6 Dec 2025
The content of VJHemOnc is intended for healthcare professionals